Paranoid psychosis and myoclonus: flecainide toxicity in renal failure. - Wikidata - wikimedia - TriplyDB

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

http://www.wikidata.org/entity/Q37122997

about

Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.Safety of flecainide.Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney Disease.The clinical heterogeneity of drug-induced myoclonus: an illustrated review.A patient with mexiletine-related psychosis.Delirium in a patient with toxic flecainide plasma concentrations: the role of a pharmacokinetic drug interaction with paroxetine.Skin biopsy-proven flecainide-induced neuropathy

P2860

Q35547234-271D78A3-D10B-4BB7-9BF9-AD17C2E008BF Q37115706-492B36CE-BB5F-4D36-8C92-85250FC2826B Q37995638-169029E2-7590-4131-BAB1-8919B25C856D Q38739039-8EFFBC31-2FD9-41EB-AFF8-AA231F690CD0 Q39040815-08E47316-824D-4567-AAA6-666F6A333194 Q39213868-052D2E09-39A5-436C-8E13-F2FDBAC502BE Q45966916-94B3BD0D-5D92-4964-B6A7-3245B8FFAC89 Q58135429-ECFAF925-BF20-4B70-8C2A-324B7071DD95

P2860

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

http://www.wikidata.org/entity/Q37122997

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@en

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@nl

type

label

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@en

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@nl

prefLabel

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@en

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@nl

P1433

Q37122997-B14AFE73-89D8-4021-AF46-EDFE475C0D70

P1476

Q37122997-FDC25341-DC95-466B-B4E1-96A872476D5B

P2093

Q37122997-6170F52D-3331-413D-AED5-2A79B95812C9

Q37122997-645747F0-A510-4F84-BDA9-74F7BE860CF8

Q37122997-6B1DB4C6-69D2-4ED1-B9B1-A4B7F19563AE

Q37122997-7F12A0C7-08D6-410B-B269-7F02245FAE60

P2860

Q37122997-3E4039E4-11A1-4C55-8377-0C2A0F94D088

Q37122997-6AB42900-D249-4D9B-938D-6E7CCE2C7535

Q37122997-6FC7AB2C-A045-4D17-B622-A1C456042DF2

Q37122997-7218FC3B-B6E1-4A70-9036-C90CB4C94B23

Q37122997-797AAD57-0073-4AFF-A6A2-0CB1DEB2FE00

Q37122997-B326DFAC-F596-4F80-A150-57EBC29F4A8D

Q37122997-D6BA9E08-AC05-416A-BDA1-CE52DE0ADCB9

Q37122997-EEEC8A41-F64D-4FC7-B85B-1365B758F98F

Q37122997-F4BEEB79-C17D-41B6-AF23-E118B92EAD8C

P304

Q37122997-06EBC6D5-6ACA-486B-8BEA-4BCAD9B2A452

P31

Q37122997-F1F68013-6238-49BD-BF8F-F2EDBD760744

P356

Q37122997-B1EB987B-0CEE-4115-8D52-FE4A41661CD0

P407

Q37122997-31441408-EC50-4FB4-A34E-46DA2423CFBB

P433

Q37122997-A3479B83-0A4A-4570-84A9-B72276D2A593

P478

Q37122997-595E99FB-2F8E-4A56-913A-9D9EC7A66A39

P577

Q37122997-9AA84AC2-0A9C-4756-9131-2AC249A9FFBD

P698

Q37122997-4A1683B8-E3D2-4D5F-BB51-1C5F9580165E

P921

Q37122997-8BDED311-5C25-4815-BD1A-77EA3F2F529C

P356

P1433

P1476

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.

@en

P2093

Douglas Lee

http://www.w3.org/2001/XMLSchema#string

Douglas Maclean

http://www.w3.org/2001/XMLSchema#string

Neil S Sheerin

http://www.w3.org/2001/XMLSchema#string

Stephen M S Ting

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin.

Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects.

Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging.

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

Pharmacokinetics of flecainide acetate in patients with severe renal impairment.

Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function.

Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.

P304

83-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000119694

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18376118

http://www.w3.org/2001/XMLSchema#string

P921